UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2018

--------------

Commission File Number: 001-34563

----------

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

--------------

18/F, Tower A, Global Trade Center

36 North Third Ring Road East, Dongcheng District

Beijing 100013

People’s Republic of China

(Address of principal executive office)

--------------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x          Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ________

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ________

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 7, 2018

Exhibit Index

Exhibit 99.1

Concord Medical Schedules 2018 Annual Meeting of Shareholders

BEIJING, December 7, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading cancer hospital operations management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2018 annual general meeting of shareholders on December 29, 2018, at 10:00 a.m. (Beijing Time). The meeting will be held at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, China. The shareholder record date is December 17, 2018. No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management. Concord Medical’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, containing the Company’s audited financial statements for the financial year ended December 31, 2017, is available in the Investor Relations section of the Company’s website at http://ir.ccm.cn. The Form 20-F is also available on the SEC’s website at http://www.sec.gov.

In October 2018, Bluestone Holdings Limited (“Bluestone”), a company indirectly wholly owned by Dr. Zheng Cheng, transferred its shares in Morgancreek Investment Holdings Limited (“Morgancreek”) (which in turn held shares in Concord Medical) to companies wholly owned by Mr. Hao Zhou and Ms. Bi Zhang, the spouse of Mr. Jianyu Yang, respectively. On the same day, all the Class A Ordinary Shares of Concord Medical held by Morgancreek were converted into Class B Ordinary Shares of Concord Medical. Morgancreek transferred 7,500,000 Class B Ordinary Shares of Concord Medical to Bluestone. Upon completion of these transactions, Mr. Zhou and Ms. Zhang indirectly hold 30% and 70% shares of Morgancreek, respectively, and Dr. Cheng holds shares of Concord Medical through Bluestone. As of the date of this announcement, Morgancreek holds 38,287,948 Class B Ordinary Shares and 4,660,976 American Depositary Shares of Concord Medical, each representing three Class A ordinary shares, and Bluestone holds 7,500,000 Class B Ordinary Shares of Concord Medical. As of the date of this announcement, the Company has 84,368,529 Class A Ordinary Shares and 45,787,948 Class B Ordinary Shares issued and outstanding. Holders of Class A ordinary shares are entitled to one vote per share, while holders of Class B ordinary shares are entitled to ten votes per share.

About Concord Medical

Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2018, the Company operated a network of 30 centers with 21 hospital partners that spanned 21 cities and 14 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.

For more information, please contact:

Concord Medical Services

Mr. Edward Zhang(Chinese and English)

+86 10 5903 6688 (ext. 608)

zhongchen.zhang@ccm.cn

Exhibit 99.2

Concord Medical Services Holdings Limited

(the "Company")

NOTICE is hereby given that an annual general meeting of the Company (the “Meeting”) will be held on December 29, 2018 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted for shareholder approval at the Meeting. Instead, the Meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management.

The board of directors of the Company has fixed the close of business on December 17, 2018 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of the Meeting or any adjournment thereof.

Holders of record of the Company’s ordinary shares at the close of business on the Record Date are entitled to attend the AGM and any adjournment or postponement thereof.

A shareholder entitled to attend the Meeting is entitled to appoint a proxy to attend on his/her behalf. A proxy need not be a shareholder of the Company. A form of proxy is attached.

To be valid, the form of proxy must be duly completed, signed and delivered (in the case of a corporation, the form of proxy should be given under such shareholder’s common seal or under the hand of an officer, attorney or other person duly authorised in writing to sign the same) to 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China for the attention of director Yang Jianyu or emailed to zhongchen.zhang@ccm.cn no later than the time for holding the Meeting or the adjourned meeting at which the proxy is to be used.

Shareholders and holders of American depositary shares of the Company may obtain a copy of the Company’s annual report on Form 20-F, containing the Company’s audited financial statements for the financial year ended December 31, 2017, from the Investor Relations section of the Company’s website at http://ir.ccm.cn or the website of the Securities and Exchange Commission at http://www.sec.gov.

By the Order of the Board of Directors,
CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Exhibit 99.3

Concord Medical Services Holdings Limited

(the “Company”)

P R O X Y

I/We* ....................................... (name) of ........................................................................................................ (address) the holder of ............... (number) shares in the Company hereby appoint ...................................... (name) of ........................................................................................................ (address) and/or* failing him/her*, ......................................... (name) of ............................................................................................................................. (address), or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf at the annual general meeting of the Company to be held on the 29th December 2018 at 10:00 a.m. (Beijing time) at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China, and at any adjournment thereof.

*Please delete as appropriate.

Date: __________________________

Signed by or on behalf of the above named

____________________________________

Name:

NOTES